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Abstract
The bone therapeutic drug zoledronate (ZOL) was loaded at and released by polyelectrolyte complex (PEC) particle
films composed of either pure poly(ethyleneimine) (PEI) or maltose-modified poly(ethyleneimine) (PEI-M) and
oppositely charged cellulose sulfate attached to model germanium (Ge) substrates by solution casting. Dispersions
of colloidally stable polyelectrolyte complex (PEC) particles in the size range 11–141 nm were obtained by mixing
PEI or PEI-M, CS and ZOL in defined stoichiometric ratios. TRANS-FTIR spectroscopy was used to determine the
stability of the PEC films against detachment, in-situ-ATR-FTIR spectroscopy for the ZOL loss in the PEC film and
UV–VIS spectroscopy for the ZOL enrichment of the release medium. Films of casted ZOL/CS/PEI-M or ZOL/CS/PEI
particles were stable in contact to water, while films of the pure drug (ZOL) and of the binary systems ZOL/PEI-M or
ZOL/PEI were not stable against detachment. Retarded releases of ZOL from various PEC films compared to the
pure drug film were observed. The molecular weight of PEI showed a considerable effect on the initial burst (IB) of
ZOL. No significant effect of the maltose modification of PEI-25 K on IB could be found. Generally, after one day the
ZOL release process was finished for all measured ZOL/PEC samples and residual amounts of 0-30% were obtained.
Surface adhesive drug loaded PEC particles are promising drug delivery systems to supply and release a defined
amount of bone therapeutics and to functionalize bone substitution materials.
Keywords: Bone healing; Interfacial drug delivery system; Polyelectrolyte complex particle; Poly(ethyleneimine);
Zoledronate; In-situ ATR-FTIR spectroscopy
Background
Functionalization of bone substitution materials (BSM)
by local interfacial delivery systems for bone therapeutic
drugs is a highly relevant strategy to improve bone
healing after fractions associated with systemic bone
diseases like osteoporosis or multiple myeloma [1].
Bisphosphonates (BP), especially nitrogen containing
ones, are current drugs of choice for the therapy of
osteoporosis [2]. Known examples of drug delivery sys-
tems (DDS) for BPs are based on calcium phosphate
phases [3], sol–gel derived titania systems [4], acrylic
bone cements [5], bisphosphonate/fatty acid salt mix-
tures [6] and poly(D, L-lactide) coatings [7]. Target of
this study is to develop an adhesive nanoparticular
bisphosphonate delivery system based on biocompatible
polyelectrolyte complexes. Typical release parameters
like initial burst, residual amount and release rate of the
drug are intended to be influenced by macromolecular
structure parameters, in a defined way for future use by
cell biologists and clinicians.
Recently, in this frame we reported on our approach
making use of polyelectrolyte (PEL) complex (PEC)
nanoparticles, that were loaded by the BP pamidronate
(PAM) and deposited as adhesive films onto planar
Ge model substrates [8]. BPs are known to inhibit
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osteoclastic activity (bone resorption) via the farnesyl
pathway favoring osteoblastic bone formation (remodel-
ing) and are widely used as therapeutics for systemic
bone diseases like osteoporosis [2]. A retarded release
of PAM under conservation and adhesive stability of the
bare PEC particle film was shown by in situ ATR-FTIR
spectroscopy, monitoring the depletion of PAM in the
cast PEC film matrix. A PEC system based on high mo-
lecular poly(ethyleneimine) (PEI-750 K) and cellulose
sulfate (CS) was used and various factors of PAM re-
lease were studied. Generally, with this system drug re-
leases were obtained, which were much more retarded
compared to releases from or dissolution of the pure
drug film.
Herein we like to follow the former work and apply
both the introduced preparative and analytical concept
on PEC systems involving cationic PEI of different mo-
lecular weights (1.3 kg/mol), 25 kg/mol, 750 kg/mol),
cationic maltose modified PEI (PEI-M) and anionic CS.
The PEI/CS system was chosen because of the high
functional group number and density of both ammo-
nium groups (PEI) and sulfate groups (CS) and the
availability of both PELs. Furthermore, especially for
branched/linear PEL combinations like PEI/CS high
structural densities enabling better drug entrapment are
expected. Moreover recent studies revealed, that among
several compositions the combination PEI/CS resulted
in a very benign interaction to human mesenchyme
stromal cells (hMSC), which was evidenced by meta-
bolic activity and fluorescence imaging studies recently
[9]. This is conflicting to studies revealing, significant
cell toxicity of uncomplexed PEI [10]. Therefore, PEC
systems composed of PEI-M are expected to provide an
enhanced biocompatibility compared to unmodified
PEI. PEI-M systems have been established in the last
years as potent carrier systems for model drugs ATP
[11,12], si-RNA and DNA [9,13] and show a benign
interaction to different relevant cell types [9,10]. Herein,
zoledronate (ZOL) was chosen, since it is to date an
established BP of choice for the systemic therapy of
osteoporosis [14] and multiple myeloma [15], which is
more potent compared to PAM. However, BPs like
PAM and ZOL are suspected for certain side effects like
accumulation in the bone matrix due to the strong BP/
calcium interaction leading to osteonecrosis [16] and
like insufficient renal clearance [17]. Therefore, the val-
idation of a local, sustainable, retarded release of a lim-
ited small amount of ZOL from PEC films at model
interfaces or BSM is a highly relevant task. In this re-
port we address and point out colloidal properties, ad-
hesiveness and retarded release of ZOL loaded PEC
particle systems based on PEI or PEI-M and CS under




Zoledronic acid was obtained from Chemos GmbH
(Regenstauf, Germany) and zoledronate (ZOL) solutions
were prepared by dissolving in 0.0002 M PBS buffer and
adjusting pH= 7.3 by addition of 0.1 M NaOH. Branched
poly(ethyleneimine) with molecular weights of 1.3 kg/Mol
(PEI-1.3 K), 25 kg/Mol (PEI-25 K) and of 750 kg/Mol
(PEI-750 K) (gift of BASF, Ludwigshafen) and cellulose
sulphate (CS, 2.900 kg/Mol, degree of substitution DS =
2.9-2.8, ACROS) were dissolved to 0.002 M solutions
related to their monomer units. PEI-M-25 K was synthe-
sized according to a protocol published therein [11].
Macromolecular structures are given in the Figure 1.
Since for PEI-M-25 K, unlike PEI-1.3 K, PEI-25 K,
PEI-750 K and CS, no defined molecular weight of the
repeating unit is available, 0.5 mg/ml PEI-M-25 K solu-
tions were prepared. To get the concentration of truly
charged monomer units of these polyelectrolytes (PEL),
colloid titration (PCD) was applied (see below). Respect-
ive factors for PEI-1.3 K, PEI-25 K, PEI-750 K and CS
were F = 0.67, 0.54, 0.70 and 2.9 L5, respectively, related
to the volume ratios of 0.001 M PEL and 0.001 M titra-
tor solution (see PCD measurements). For 0.5 mg/ml
PEI-M a respective factor F = 0.90 was obtained. PBS
buffer was prepared from respective buffer tablets. Ge
internal reflection elements (IRE) were obtained from
Komlas GmbH, Berlin.
Preparation of drug loaded polyelectrolyte complex (PEC)
particles
For PEI and CS solutions of 0.002 M and for PEI-M
solutions of 0.5 mg/ml were prepared in 0.0002 M PBS
buffer, respectively. This unusually low PBS concentration
was applied for analytical reasons concerning bisphos-
phonate detection by ATR-FTR spectroscopy (see below).
For the preparation of binary ZOL/polycation samples de-
fined volumes (1–5 ml) of polycation (PC: PEI or PEI-M)
solutions were incubated with varying volumes of a
0.01 M ZOL in 0.0002 M PBS buffer solution under stir-
ring to get stoichiometric ratios ZOL/PC of 1:5 related to
the molar concentration of ZOL molecules and charged
monomer units of PC. For the preparation of ternary
ZOL/CS/PC samples defined volumes of 0.002 M CS solu-
tions were mixed slowly to the binary ZOL/PC solutions
under stirring to get stoichiometric ratios CS/PC of either
n-/n + = 0.9 or n-/n + = 1.1 related to the molar concen-
tration of charged monomer units of CS and PC. For the
CS/PEI combination such prepared ternary PEC samples
are denoted as ZOL/CS/PEI-0.9-1:5 or ZOL/CS/PEI-1.1-
1:5. For CS/PEI-0.9 dispersions CS (minority) was dosed
into PEI (majority), while for CS/PEI-1.1 dispersions
PEI (minority) was dosed into CS (majority) solutions,
whereby in both cases at first ZOL solutions were given
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to PEI solutions. Finally, 10 microliter of 0.01 M CaCl2
solution were added to 200 microliter of the ZOL/PEI/
CS dispersions.
Deposition of drug loaded PEC particles and drug release
3 × 16.6 microliter (totally ≈50 microliter) of the re-
spective ZOL/CS/PEI/CaCl2 mixture in 0.2 mM PBS de-
scribed above were consecutively solution casted onto
the Ge IRE to homogeneous films and dried at 50°C in
the vacuum oven for 30 min on top of each other, re-
spectively. For the ternary ZOL/CS/PEI-750 K-0.9-1:5
system such a film contains a ZOL mass of ≈ 4.6 μg. ZOL
release was initiated by the direct contact of the ZOL/PEC
films to 0.1 mg/ml PBS buffer (release medium). ZOL re-
lease was measured by in-situ ATR-FTIR spectroscopy
(see below). Each sample was measured in the dry state,
after 5, 30, 60, 120 and 1200 min in triplicate, respectively.
Colloid titration
Concentrations of charged monomer units of PELs used
in this study were determined by the Particle Charge
Detector (PCD, Mutek, Herrsching, Germany) according
to standard protocols using low molecular 0.001 M
PDADMAC or 0.001 M PVS solutions as titrating solu-
tions. In principle sample solutions or dispersions bear-
ing charged species (polymers, particles) are titrated by
either PDADMAC or PVS until the zeta-potential mea-
sured upon moving a PTFE piston within a PTFE vessel
is zero. Herein two titration modes i.e., a slow (titration
steps of 10 μl) and a rapid titration mode (titration steps
of 50 μl) were used (see titration curves in Additional
file 1). The true concentration of charged monomer
units in the PEL solutions, whose initial concentration
was 0.002 M, related to their both charged and uncharged
monomer units, was calculated from the consumed
amount of the titrator solution. The true concentration of
charged monomer units was always smaller compared to
the monomer unit concentration of 0.002 M. The ratio
between true charged monomer and monomer concentra-
tion can be expressed by the factor F (see above).
Dynamic light scattering (DLS)
ZOL/PEC and PEC particle sizes were determined by dy-
namic light scattering (DLS) at the Jianke Portable Particle
Sizer (Jianke Instruments Co. Ltd, Wuhu, P.R. China)
using a scattering angle of 90°. The samples were hold in
10 mm cuvettes with circular bottom. The hydrodynamic
radius RH was estimated using the Stokes-Einstein equation.
Intensity weighted DLS data were considered, as it was
applied earlier therein [18]. Errors of RH are related
to the standard deviation of at least three different
measurements. The ALV-5000/E/EPP-Software of ALV
GmbH, Langen, Germany was used for calculations of
DLS parameters.
Ex-situ TRANS-FTIR spectroscopy
TRANS-FTIR was applied using the Ge IRE taken for
the in-situ-ATR-FTIR spectra. These Ge IREs were
mounted at standard sample holders and the IR beam
transmitted the Ge-IRE at its focus. FTIR spectra were
recorded taking uncoated Ge-IREs as reference and
coated ones as sample. The coated ones were measured
in the initial dry state (t = 0 min) and after contact to
water for defined release times (t = 1, 60, 1200 min) and
subsequent drying. After actual measurements the dry
coated Ge-IREs were again contacted to the release
medium for a defined period and again taken out and
dried for the next measurements. Film stability was
checked by the constancy or decrease of diagnostic IR
bands of the polymer film matrix.
In-situ ATR-FTIR spectroscopy
ZOL/PEC films deposited onto Ge internal reflection
elements (IRE) were characterized by in-situ-ATR-FTIR
spectroscopy using the SBSR concept [19] resulting in well
compensated ATR-FTIR spectra. A dedicated ATR-FTIR
Figure 1 Chemical formulae of PEI-XK, PEI-M-25 K and CS.
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attachment (OPTISPEC, Zurich, Switzerland) was operated
on the IFS 55 Equinox spectrometer (BRUKER Optics
GmbH, Ettlingen, Germany) equipped with globar source
and MCT detector. 100 scans were collected at spectral
resolution of 2 cm-1 using Happ-Gänzel apodisation for
each recorded spectrum. Quantification of concentrations
c at polymer films by ATR-FTIR spectroscopy is based on
the absorbance or integral A of a given IR band using a
modified Lambert-Beer law according to Fringeli [19] and
Harrick [20], which is given in equation (1):
A ¼ NεcdE ð1Þ
Equation (1) includes the number of reflections N =
11, absorption coefficient ε of the given band and the ef-
fective thickness dE instead of the true sample thickness
d in TRANS-FTIR. The value of dE can be calculated
knowing the refractive indices n1, n2, n3 of the IRE, poly-
mer and bulk medium, respectively, depth of penetration
dP and incident angle θ of the IRE. Earlier it has been
shown, that band integrals from ATR-FTIR spectra are
directly proportional to the molar amount of IR absorb-
ing monomer units or components in polymer films, if
the thickness of the polymer film does not exceed
around 300 nm (thin film case) [21]. For casted PEC
films used in this report this assumption was valid. ZOL
release from the PEC films was measured in the dry
state (t = 0 min) and after defined times (t = 5, 30, 60,
120, 1200 min) of contact to the release medium in the
wet state.
Spectral curve fitting analysis and quantification of actual
ZOL content
The diagnostic but highly overlapped ATR-FTIR spectral
region between 1320 and 900 cm-1 on ZOL/PEC films
was analysed by the curve fitting routine of the OPUS
software (BRUKER Optics GmbH, Ettlingen, Germany)
following a procedure, which was reported recently and
therein applied on the pamidronate/PEC system [8].
UV/VIS spectroscopy
UV–VIS spectra were recorded at the spectropolarimeter
J810 (JASCO, Großumstadt, Germany), equipped with an
air cooled powerful Xenon source (150 W), piezoelastic
modulator and head-on photomultiplier tube as detector
in the range 163–900 nm, which enabled the detection of
very low ZOL concentrations in the release medium.
Scanning force microscopy (SFM)
SFM images were recorded from casted films of the ZOL/
PEC and ZOL free PEC particles by the device Nanostation
II of Bruker Nano GmbH (Karlsruhe, Germany) using sili-
con probe tips from Nanosensors (Darmstadt, Germany)
having radii of around 10 nm. Dry film samples on the Ge
IRE used for ATR-FTIR were measured in “non-contact
mode” under room conditions in topography, error and
phase mode and scanning parameters were optimized by
minimizing the signal in the error mode. The thickness of
PEC films was determined at scalpel cutted film regions
based on the height difference between undamaged film
and naked Ge surface. Surface profiles were generated
from SFM raw data by the SISCANPro software (BRUKER
Nano GmbH, Karlsruhe, Germany) using SFM images in
topography mode.
Results and discussion
Size of PEC particles
Particle sizes of unloaded and ZOL loaded (ZOL/PEC-1:5)
complexes of PEI-1.3 K/CS, PEI-25 K/CS, PEI-750 K/CS
and PEI-M-25 K-1:5/CS were determined by dynamic
light scattering (DLS). Both PEC-0.9 and PEC-1.1 samples
were prepared and analysed, respectively. In the Table 1
hydrodynmic radii (RH), count rates and assumed net
charges for these PEC samples are shown. Particle sizes in
the range RH = 11–141 nm were obtained and PEC disper-
sions showed colloidal stability (only ZOL/CS/PEI-1.3 K-
0.9-1:5 tended to colloidal instability) in the sense, that
PEC particles do not aggregate at a significant rate.
Obviously, both sizes and count rates for PEC-1.1
particles were in nearly all cases smaller compared to
PEC-0.9 particles. Since it is claimed, that PEC particles
consist of a neutral charge compensated core and a shell
of the respective excess PEL component [22], the
branched polycations PEI-1.3 K, PEI-25 K, PEI-M-25 K
and especially PEI-750 K are assumed to form a larger
shell compared to the linear CS. Loading of ZOL into
PEC particles generally enlarged particle sizes with ex-
ception of the CS/PEI-25 K-0.9 system.
No distinct molecular weight effect of PEI on the par-
ticle size was found for bare (unloaded) PEC-0.9 and
PEC-1.1 particles containing unmodified PEI. CS/PEI-
1.3 K particles seem to be smallest, but these RH values
are based on low count rate values. This finding is based
on the fact, that herein prepared secondary PEC parti-
cles are composed of several aggregated primary PEC
particles and primary PEC particles are composed of few
oppositely charged PEL [22,23]. Hence in PEC particles
with low molecular PEI more macromolecules are in-
cluded but the particle size is around constant. However
ZOL loaded PEC-0.9 and PEC-1.1 particles show a mo-
lecular weight dependence of particle size. Presumably,
high molecular PEI-750 K can uptake or store more
ZOL molecules compared to lower molecular PEI-25 K
or PEI-1.3 K in their respective complexes with CS.
Stability of PEC particle films
The stability against detachment of the pure ZOL, the bin-
ary mixture ZOL/PEI-M and the ternary PEC dispersion
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ZOL/CS/PEIM casted onto the Ge model substrate was
measured by TRANS-FTIR spectroscopy. In the Figure 2
TRANS-FTIR spectra of solution casted films of pure
ZOL (a), ZOL/PEI-M-1:1 (b) and of ZOL/CS/PEI-M-25
K-1.1-1:5 (c) are shown for the initial freshly casted dry
state (black) and the end dry state after contact to water
for one day and subsequent drying (blue).
The TRANS-FTIR mode was chosen, since it has sen-
sitivity for loss processes through the whole thickness of
the ZOL/PEC films regardless if thin or thick. Whereas,
the ATR-FTIR mode is more sensitive for loss processes
in zones of PEC films close to the substrate, since the
evanescent field decays exponentially and losses in outer
film regions of thick films are detected with less sensitiv-
ity compared to those of thin films (see Experimental).
Poor film stability at the Ge substrate was found for the
casted pure ZOL solution (a) and the binary mixture
ZOL/PEI-M-25 K-1:1 (b), which can be rationalized by
the nearly complete vanishing of the initial dry spectrum
intensity (black), so that only traces of ZOL or ZOL/
PEI-M-25 K-1:1 (blue) were present. Whereas, good film
stability was found for the casted ternary PEC dispersion
of ZOL/CS/PEI-M-25 K-1.1-1:5 (c), whose film thickness
ranged around 200 nm determined by AFM cuts. Obvi-
ously, only the ternary ZOL/CS/PEI-M-25 K-1.1-1:5 sys-
tem was stable against dissolution and detachment by
the release medium. We argue, that the ZOL/CS/PEI-M-
25 K-1.1-1:5 particles in their casted films undergo a
process of partly shrinking, flattening and merging upon
drying and water loss, leading to films comparably stable
against detachment like those of latex particles used e.g.
as paints [24,25]. Furthermore, in the Figure 3 the long-
term adhesive stability of this PEC film rationalized by
the intensity of the PEC diagnostic ν(O = S = O) band
versus time for ZOL/CS/PEI-M-0.9-1:5 (a) and ZOL/CS/
PEI-M-1.1-1:5 (b) is shown.
The value for the initial dry state was taken to normalize
all later states. Generally, no significant decrease from the
initial 100% value could be obtained, which is a direct
proof of the stability of all PEC films against detachment.
Moreover, there was a slight percentage increase for the
PEC-1.1 samples, which might be caused on the one hand
by band shifts of the ν(O = S =O) band between the initial
dry and the successive dry states after rinsing. On the other
hand we attribute this effect to the compaction of the PEC
phase, when the initially casted PEC films undergo struc-
tural rearrangements in contact to water, so that the subse-
quent drying steps result in denser structures compared to
Table 1 Sizes (RH), count rates and net charge signs for
various PEC samples




CS/PEI-1.3 K-0.9 42 ± 5 19 (+)
CS/PEI-1.3 K-1.1 11 ± 5 4* (−)
ZOL/CS/PEI-1.3 K-0.9-1:5 416 ± 10** 5* (+)
ZOL/CS/PEI-1.3 K-1.1-1:5 45 ± 5 72 (−)
CS/PEI-25 K-0.9 73 ± 5 87 (+)
CS/PEI-25 K-1.1 28 ± 5 6 (−)
ZOL/CS/PEI-25 K-0.9-1:5 70 ± 5 119 (+)
ZOL/CS/PEI-25 K-1.1-1:5 62 ± 5 92 (−)
CS/PEI-750 K-0.9 60 ± 10 110 (+)
CS/PEI-750 K-1.1 35 ± 6 20 (−)
ZOL/CS/PEI-750 K-0.9-1:5 105 ± 10 215 (+)
ZOL/CS/PEI-750 K-1.1-1:5 73 ± 5 138 (−)
CS/PEI-M-25 K-0.9 71 ± 5 6 (+)
CS/PEI-M-25 K-1.1 53 ± 5 4* (−)
ZOL/PEI-M-25 K-0.9-1:5 95 ± 10 25 (+)
ZOL/PEI-M-25 K-1.1-1:5 141 ± 5 11 (−)
*very low countrate **unstable sample (aggregation).
Figure 2 TRANS-FTIR spectra of solution casted films at Ge-IRE substrates. FTIR spectra on pure ZOL (a), ZOL/PEI-25 K-M-1:1 (b) and ZOL/
CS/PEI-25 K-M-1.1-1:5 (c) for the initial dry state (0 min, black, bottom) and the end dry state after 1 day contact to release medium (blue, top)
are given.
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the initial one. This supports the shrinking/merging sce-
nario raised before as an argument for the good PEC film
stability against detachment. Especially, drug loaded
PEC films are assumed to be prone for this effect, since
the space formerly filled by the drug (ZOL) is now filled
with pure PEC material. Finally, it has to be pointed out,
that the film stability proven herein is a prerequisite for
the functionalization of BSM like bone cements or
implants by interfacial drug delivery systems (DDS) in
future clinical applications. Obviously, of the drug
delivery systems assessed in this work, the ternary drug/
polycation/polyanion systems fulfill this requirement in
contrast to the binary drug/polycation systems.
Morphology of PEC films
Additionally, AFM measurements on the freshly pre-
pared dry films and on those after the contact with
water were performed. In the Figure 4 AFM images of
ZOL/CS/PEI-XK-0.9-1:5 and ZOL/CS/PEI-M-25 K-0.9-1:5
Figure 3 Stability of ZOL loaded PEC films at Ge-IRE substrates against detachment. The ν(SO2) band integral from TRANS-FTIR spectra of
thin PEC-0.9 (a) and PEC-1.1 (b) films of ZOL/CS/PEI-M-25 K-1:5 (cubes), ZOL/CS/PEI-25 K-1:5 (triangles) and ZOL/CS/PEI-750 K-1:5 (circles) is
plotted versus time (0, 1, 60, 1200 min) of contact to release medium (dry state).
Figure 4 AFM images of solution casted ZOL loaded PEC films on Ge-IRE substrates. AFM images (topography, 4 × 4 um) are shown in the
dry state before (top row) and after release (bottom row). In the left column films of ZOL/CS/PEI-M-25 K-0.9-1:5, the middle column those of ZOL/
CS/PEI-25 K-0.9-1:5 and right column of ZOL/CS/PEI-750 K-0.9-1:5 are given.
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films after water contact for one day and subsequent
drying are shown.
At first, no significant difference between respective
AFM images of the freshly casted film (top) and the
rinsed film (bottom), after drying respectively, could be
observed. This finding supports the stability of ZOL/
PEC films after contact to the release medium. Secondly,
small PEC particles, whose diameters were sizing around
100 nm could be found. This value can not be directly
compared to diameters found by DLS measurements
(Table 1), since on the one side casted PEC particles are
flattened and are assumed to have a hemispheric profile
[26] leading to larger values. On the other side, dried
casted PEC particles lost water to a considerable
amount leading to smaller values compared to diame-
ters obtained from DLS. Which effect, flattening or
shrinking, is dominating or whether both approximately
compensate, cannot be figured out exactly. Nevertheless
we speculate that drying of casted PEC films is associ-
ated with a process of shrinking, flattening and partly
merging of individual PEC particles. This results in the
remarkable stability of PEC particle films against de-
tachment (see above).
Zoledronate release from PEC films
ZOL release was determined as the drug loss in the
polymer film by in-situ ATR-FTIR spectroscopy, which
is linearly sensitive to concentration changes of a variety
of surface active compounds (e.g. drugs, polyelectrolytes,
proteins) at and in thin films, whose thickness is not ex-
ceeding around 300 nm [21,27-30]. In the Figure 5 typ-
ical ATR-FTIR spectra recorded during ZOL release
from thin PEC films of ZOL/CS/PEI-M-25 K-0.9-1:5 (a)
and ZOL/CS/PEI-750 K-0.9-1:5 (b) for the initial (black)
and end dry state (red) and for the contact to release
medium (blue) after 5–1200 min (≈1 day) are shown.
Significant changes in the range between 1200 and
1000 cm-1, in which diagnostic IR bands of ZOL appear,
were obtained. An assignment of these IR bands is given
in the Table 2.
Since this spectral region is highly overlapped, the
exact intensities (absorbances, integrated areas) of these
bands have to be obtained by line shape analysis of the
spectral region between 1300 and 900 cm-1, which was
introduced for another drug/PEC system therein [8].
Generally, from the ratio of band intensities assigned to
ZOL and those assigned to the PEC (CS) the actual rela-
tive amount of ZOL in the PEC film can be obtained
(see Methods). In the Figure 6a kinetic curves of the per-
centage content values of ZOL normalized by the initial
content are shown for the ZOL loaded PEC-0.9 systems
of CS/PEI-M-25 K, CS/PEI-25 K and CS/PEI-750 K, re-
spectively. Additionally, in the Figure 6b kinetic curves
of the ZOL loaded PEC-1.1 systems of CS/PEI-M-25 K,
CS/PEI-25 K and CS/PEI-750 K are given.
A significant retardation of drug release with respect
to the pure ZOL film can be rationalized for all ZOL/
PEC samples. Obviously, there is a retention of the drug
in the PEC matrix, whose initial amount is around 4.6 μg
per PEC film sample (see Experimental). This amount
could be easily increased to compare e.g. with that of ZOL
loaded poly(D,L-lactide) (PDLLA) coatings used to modify
intramedullary implants healing fractures of rat tibia
containing 20 μg ZOL as reported by Greiner [7].
Two parameters could be read out further from these
curves. At first the initial burst (IB) can be rationalized
from the difference between 100% at time zero and a
given percentage after 5 min. Secondly, from the per-
centage value at the end of the observed release process
(typically after around one day) the residual amount
(RA) of the drug can be obtained. In Table 3 values of IB
and RA of the various PEC samples are summarized.
Figure 5 ATR-FTIR spectra of solution casted ZOL loaded PEC films. Kinetic FTIR spectra series for ZOL/CS/PEI-M-25 K-0.9-1:5 (a) and ZOL/CS/
PEI-750 K-0.9-1:5 (b) are provided for the initial (black) and end dry state (red) and the contact to the release medium (5–1200 min, blue).
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At first, for all three unmodified PEC samples the IB
values decreased significantly with the molecular weight,
resulting in lower IB values (37-39%) for the PEI-750 K/CS
systems and higher IB values (72-75%) for the PEI-1.3
K/CS system. Presumably, the hyperbranched PEI struc-
ture serves as a sponge for oppositely charged compounds
like the drug bisphosphonate, for which counter ion con-
densation might be seen as a major driving force. Hence,
the higher molecular weight PEI might provide a larger dif-
fusion region compared to lower molecular weight PEI,
when the PEC film gets hydrated and dissolution and
release of the drug sets in. This result is supported by
data provided in the additional information, where high
molecular PEI-750 K showed also an insufficient titra-
tion behavior even in the slow titration mode due to
longer diffusion times. However, no significant molecu-
lar weight effect on the RA values could be found for
the unmodified PEC samples. Obviously, the drug re-
lease process for all studied PEC systems stopped or
highly delayed after around one day.
Secondly, no large differences in both IB and RA
values could be identified between the maltose modified
PEC samples of ZOL/CS/PEI-M-25 K (IB: 21-57%, RA:
6-12%) and the unmodified samples of ZOL/CS/PEI-
25 K (IB: 27-54%, RA: 0-8%), respectively. Both PEC
samples are based on the same PEI molecular weight
containing equal amounts of charges. Thus, we assume,
that ZOL interaction to these PEC samples is governed
by electrostatic attraction between negatively charged
ZOL and oppositely charged PEI-25 K or PEI-M-25 K.
Thirdly, the net charge of all ZOL/PEC particle system
shows no clear effect on IB and RA for PEC systems
containing low molecular PEI-1.3 K and PEI-25 K. The
RA values for both PEI molecular weights cases and for
PEC-0.9 and PEC-1.1 particles are low. Whereas, for the
PEI-750 K containing system PEC-1.1 particles show a
moderate (27%) and PEC-0.9 particles a low RA value
(10%) and the IB values for PEC-0.9 and PEC-1.1 parti-
cles are similar and moderate. Hence, we conclude, that
a high PEI molecular weight and the PEC-1.1 particle
system show actually the best release performance.
Zoledronate enrichment of the release medium
Parallel to the ATR-FTIR data on ZOL loss of the polymer
films, ZOL enrichment of the release medium was mea-
sured by UV–VIS-spectroscopy. A concentration series of
UV–VIS spectra on ZOL solutions is given in the Figure 7a
and the related calibration plot in Figure 7b.
According to these spectra and the calibration plot a
concentration of around 0.00001 M (10-5 M) of ZOL can
be detected conveniently. A respective kinetics of ZOL
enrichment is plotted versus time for ZOL/CS/PEI-750
K-1.1-1:2 in the Figure 7c. The known ZOL content in the
PEC film was taken as 100%. The concentration enrich-
ment shows an initial burst after 5 min of around 40%.
Afterwards the released ZOL concentration increases
Table 2 Assignment of diagnostic IR bands between 1300
and 800 cm-1 in ZOL/CS/PEI(M) samples







Figure 6 Release kinetics of ZOL from PEC films. The relative ZOL content for PEC-0.9 (a) and PEC-1.1 (b) systems of ZOL/CS/PEI-M-25 K-1:5
(cubes), ZOL/CS/PEI-25 K-1:5 (triangles) and ZOL/CS/PEI-750 K-1:5 (circles) samples is plotted versus exposure time (0, 5, 30, 60, 120, 1200 min) to
the release medium (0.1 mg/ml PBS). For comparison the kinetic curve for a pure ZOL film (black) is shown.
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further and levels off at a concentration cZOL = 0.00006 M,
which corresponds to a release of ~41.3 μg ZOL from the
polymer film within 2 hours. Comparable ZOL amounts
were used by Greiner [7] for the release from PDLLA
films on intramedullary implants for rat tibia fixation.
Concerning a physicochemical description of the release
kinetics several models are known. Herein, we applied the
kinetic analysis according to the classical Ritger/Peppas
model [31] to represent the UV–VIS data on ZOL release
given in Figure 7c see (Additional file 2). Generally, from
this analysis dissolution rather than diffusion of ZOL at
PEC films was concluded.
Conclusions
-Colloidally stable dispersions of polyelectrolyte com-
plex (PEC) particles loaded by osteotherapeutic zole-
dronate (ZOL) in the size range 11–141 nm could be
prepared by mixing pure (PEI) or maltose-modified poly
(ethyleneimine) (PEI-M) with cellulose sulfate (CS) in
the presence of ZOL.
-Casted films of ternary ZOL/CS/PEI-M or ZOL/
CS/PEI PEC particles were stable in contact to water,
while films of the pure drug (ZOL) and of the binary
system ZOL/PEI-M or ZOL/PEI were not stable
against detachment.
-ZOL release from PEC films could be detected by
in-situ ATR-FTIR (drug loss in the PEC film) and by
UV–VIS spectroscopy (drug enrichment in the release
medium). As release parameters the initial burst (IB)
after 5 minutes and the residual amount (RA) after one
day were read out from these data.
-Retarded releases of ZOL from various PEC films
compared to the pure drug film were observed. Generally,
after one day the ZOL release process was finished
for all measured ZOL/PEC samples and RA values be-
tween 0-27% were obtained. With increasing molecular
weight, IB values decreased due to slower diffusion times
of ZOL out of the PEC samples, so that actually, PEC-1.1
particles of CS/PEI-750 K have the best release perform-
ance (IB = 37%, RA = 27%). No significant effect of the
maltose modification of PEI-25 K neither on IB nor on
RA could be found.
-Generally, we conclude that IB values are acceptable,
but RA values after one day are actually too low for
long-term clinical applications. Assuming molecular
ZOL dimensions < 1 nm, we consider compactness as
the main molecular parameter influencing ZOL reten-
tion in the PEC based delivery systems. Therefore future
achievements will be addressed to densify the PEC
matrix further by using additional biocrosslinkers and
Table 3 Initial burst (IB, after 5 min) and residual amount
(RA, after 1200 min) values for various PEC samples
PEC sample IB / [%] RA / [%]
ZOL/CS/PEI-1.3 K-0.9-1:5 72 ± 5 9 ± 5
ZOL/CS/PEI-1.3 K-1.1-1:5 75 ± 5 0 ± 5
ZOL/CS/PEI-25 K-0.9-1:5 54 ± 5 0 ± 5
ZOL/CS/PEI-25 K-1.1-1:5 27 ± 5 8 ± 5
ZOL/CS/PEI-750 K-0.9-1:5 39 ± 5 10 ± 5
ZOL/CS/PEI-750 K-1.1-1:5 37 ± 5 27 ± 5
ZOL/CS/PEI-M-25 K-0.9-1:5 57 + 5 6 + 5
ZOL/CS/PEI-M-25 K-1.1-1:5 21 + 5 12 + 5
Figure 7 UV–VIS studies on the enrichment of the release medium (0.1 mg/ml PBS) by ZOL. UV–VIS spectra of ZOL solutions in the
concentration range cZOL = 0.00001-0.0001 M (a), the calibration curve for ZOL solutions in the concentration range cZOL = 0.00001-0.0001 M (b)
and the kinetics of ZOL enrichment released from ZOL/CS/PEI-750 K-1.1-1:2 particle films (c) are given.
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further PEL combinations enabling smaller mesh and
pore sizes and involving additional molecular inter-
action forces. Nevertheless, the PEL complexation con-
cept for controlled delivery of ZOL offers an additional
advantage: While for systemic medication large amounts
in the range of milligrams of ZOL are used, ZOL/PEC
films contain ZOL in the range of micrograms. Herein
4.6 μg ZOL are provided per film sample, which can be
easily upscaled to be large enough for local therapy (see
[7]) and preventing systemic side effects.
-Finally PEC particles have already started to be ap-
plied at relevant bone substituting materials like bone
cements or implants and tested for their biocompatibil-
ity and interaction to bone cells [9]. In final conclusion,
surface adhesive drug loaded PEC particles are promis-
ing drug delivery systems to supply and release a defined
amount of bone therapeutics from BSM.
Additional files
Additional file 1: Molar amount of PEL charges. Colloid titration
results on PEI-25 K, PEI-750 K, PEI-M-25 K, CS.
Additional file 2: Kinetic analysis of ZOL release from PEC films.
Results based on the model of Ritger/Peppas.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
BT, DV and BU prepared ZOL loaded PEC dispersions and carried out the
in-situ-ATR-FTIR measurements. DV carried out the UV–VIS measurements. SS
and DA synthesized and supplied the PEI-M-K25 sample. MM, BT and DV
designed the in-situ-ATR-FTIR experiments. BT, DA and MM drafted and
iteratively refined the manuscript. All authors approved the final manuscript.
Acknowledgements
This work is related to the Special Research Area / Transregional 79 (TRR 79,
part project M7) entitled Materials for Tissue Regeneration in Systemically
Diseased Bones of Deutsche Forschungsgemeinschaft (DFG) involving
universities and research institutes in Gießen, Heidelberg and Dresden,
Germany. S. Salem thanks the DAAD for the grant (No. A1092651).
Received: 13 August 2013 Accepted: 9 September 2013
Published: 11 September 2013
References
1. Su K, Shi X, Varshney R, et al. (2011) Transplantable delivery systems for in
situ controlled release of bisphosphonate in orthopedic therapy. Expert
Opin Drug Deliv 8:113–126
2. Kavanagh KL, Guo KD, Dunford JE (2006) The molecular mechanism of
nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc Natl
Acad Sci 103(20):7829–7834
3. Peter B, Pioletti DP, Laib S, et al. (2005) Calcium phosphate drug delivery
system: influence of local zoledronate release on bone implant
osteointegration. Bone 36(1):52–60
4. Linderback P, Areva S, Aspenberg P, Tengvall P (2010) Sol–gel derived
titania coating with immobilized bisphosphonate enhances screw fixation
in rat tibia. J Biomed Mat Res Part A 94A(2):389–395
5. Yu NYC, Ruys AJ, Zenios M, Godfrey C, McDonald M, Kiely P, Mikulec K, Little
DG, Schindeler A (2008) Bisphosphonate-laden acrylic bone cement:
Mechanical properties, elution performance, and in vivo activity. J Biomed
Mater Res Part B 87B:482–491
6. Kautz AR, Grunow E, Schlottig F, Schnabelrauch M (2007) Bisphosphonate
based coatings for hard tissue implants. Eur Cells Mat 14(Suppl 1):68
7. Greiner SH, Wildemann B, Back DA, Alidoust M, Schwabe P, Haas NP,
Schmidmaier G (2008) Local application of zoledronic acid incorporated in a
poly(D, L-lactide)-coated implant accelerates fracture healing in rats. Acta
Orthop 79(5):717
8. Müller M, Keßler B (2012) Release of pamidronate from poly(ethyleneimine)/
cellulose sulphate complex nanoparticle films: An in-situ ATR-FTIR study. J
Pharm Biomed Anal 66:183–190
9. Woltmann B, Torger B, Müller M, Hempel U (2013) Interaction between
immobilized polyelectrolyte complex nanoparticles and human
mesenchymal stromal cells. Biomaterials. submitted
10. Parhamifar L, Larsen AK, Hunter AC, Adresden TL, Moghimi SM (2010)
Polycation cytotoxicity: a delicate matter for nucleic acid therapy-focus on
polyethylenimine. Soft Matter 6:4001–4009
11. Appelhans D, Komber H, Abdul Quadir M, Loos A, Schwarz S, Richter S,
Aigner A, Müller M, Haag R, Voit B (2009) Hyperbranched PEI with various
oligosaccharide architectures: Synthesis, characterization, ATP complexation
and cellular uptake. Biomacromolecules 10:1114–1124
12. Polikarpov N, Appelhans D, Welzel P, Kaufmann A, Dhanapal P, Bellmann C,
Voit B (2012) Tailoring uptake and release of ATP by hybrid hydrogel
composed by dendritic glycopolymer and PNIPAAm: First approaches
towards multicompartment release systems. New J Chem 36:438–451
13. Höbel S, Loos A, Appelhans D, Schwarz S, Seidel J, Voit B, Aigner A (2011)
Maltose- and maltotriose-modified hyperbranched poly(ethyleneimine)s
(OM-PEIs): Physicochemical and biological properties of DNA and siRNA
complexes. J Control Release 149:146–158
14. Black DM, Delmas PD, Eastell R (2007) Once-yearly zoledronic acid for
treatment of postmenopausal osteoporosis. N Engl J Med
356(18):1809–1822
15. Rosen LS, Gordon D, Kaminskiy M (2001) Zoledronic acid versus
pamidronate in the treatment of skeletal metastases in patients with breast
cancer or osteolytic lesions of multiple myeloma: A phase III, double-blind,
comparative trial. Cancer J 7(5):377–387
16. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P (2007)
Prevalence, risk factors and clinical characteristics of osteonecrosis of the
jaw (ONJ) in osteoporosis patients treated with bisphosphonates. Clin Ther
29:1548–1558
17. Miller PM (2011) The kidney and bisphosphonates. Bone 49:77–81
18. Müller M, Keßler B, Richter S (2005) Preparation of monomodal
polyelectrolyte complex nanoparticles of PDADMAC/poly(maleic acid-
alt-α-methylstyrene) by consecutive centrifugation. Langmuir 21
(15):7044–7051
19. Fringeli UP (2000) ATR and Reflectance IR spectroscopy: Applications. In:
Lindon JC, Tranter GE, Holmes JL (ed) Encyclopedia of Spectroscopy and
Spectrometry. Academic Press, London
20. Harrick NJ (1981) Internal Reflection Spectroscopy. Harrick, Ossining, New
York
21. Müller M, Paulik S (2008) in-situ-ATR-FTIR and AFM studies on the influence
of adsorption time on deposition and nanostructure of poly(ethyleneimine)/
poly(acrylic acid) multilayers. Macromol Symp 265:77–88
22. Philipp B, Dautzenberg H, Linow KJ, Kötz J, Dawydoff W (1989)
Polyelectrolyte complexes -Recent developments and open problems. Progr
Polym Sci 14:91–172
23. Starchenko V, Müller M, Lebovka N (2008) Growth of polyelectrolyte
complex nanoparticles: Computer simulations and experiments. J Phys
Chem C 112(24):8863–8869
24. Hahn K, Ley G, Oberthur R (1988) On particle coalescence in latex films (II).
Coll Polym Sci 266:631–639
25. Wang YC, Winnik MA (1993) Polymer diffusion across interfaces in latex
films. J Phys Chem 97(11):2507–2515
26. Ouyang W, Müller M (2006) Monomodal polyelectrolyte complex
nanoparticles of PDADMAC/poly(styrenesulfonate): Preparation and protein
interaction. Macromol Biosci 6(11):929–941
27. Torger B, Müller M (2013) in-situ-ATR-FTIR analysis on the uptake and
release of streptomycin from polyelectrolyte complex layers. Spectrochim
Acta A 104:446–453
28. Müller M, Keßler B (2011) Deposition from dopamine solutions at Ge
substrates: An in situ ATR-FTIR study. Langmuir 27(20):12499–12505
29. Müller M, Keßler B, Houbenov N, Bohata K, Pientka Z, Brynda E (2006) pH
dependence and protein selectivity of poly(ethyleneimine)/poly(acrylic acid)
multilayers studied by in-situ ATR-FTIR spectroscopy. Biomacromolecules
7(4):1285–1294
Torger et al. Biointerphases 2013, 8:25 Page 10 of 11
http://www.biointerphases.com/content/8/1/25
30. Bittrich E, Burkert S, Müller M, Eichhorn KJ, Stamm M, Uhlmann P (2012)
Temperature-sensitive swelling of poly(N-isopropylacrylamide) brushes with
low molecular weight and grafting density. Langmuir 28(7):3439–3448
31. Ritger PL, Peppas NA (1987) A simple equation for description of solute
release. I. Fickian and non-Fickian release from non-swellable devices in the
form of slabs, spheres, cylinders or discs. J Control Release 5:23–36
doi:10.1186/1559-4106-8-25
Cite this article as: Torger et al.: Cast adhesive polyelectrolyte complex
particle films of unmodified or maltose-modified poly(ethyleneimine)
and cellulose sulphate: fabrication, film stability and retarded release of
zoledronate. Biointerphases 2013 8:25.
Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Torger et al. Biointerphases 2013, 8:25 Page 11 of 11
http://www.biointerphases.com/content/8/1/25
